Amphastar Pharma (AMPH) Tops Q3 EPS by 11c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2016
November 8, 2016 4:05 PM ESTReports Net Revenues of $64.2 Million for the Three Months Ended September 30, 2016
RANCHO CUCAMONGA, Calif., Nov. 08, 2016 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (Amphastar or the Company) today reported results for the three months ended September 30, 2016.
Third Quarter Highlights
Net revenues of $64.2 million for the third quarterGAAP net income of $3.9 million, or $0.08 per diluted share for the third quarterAdjusted non-GAAP net income of $6.6 million, or $0.14 per diluted share for the third... More